94 related articles for article (PubMed ID: 19239975)
1. Acute interstitial pneumonitis after implantation of paclitaxel-eluting stents: a report of two fatal cases.
Fujimaki T; Kato K; Fukuda S; Watanabe K; Mori T; Hibino T
Int J Cardiol; 2011 Apr; 148(2):e21-4. PubMed ID: 19239975
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-induced interstitial pneumonia after drug-eluting stent implantation: report of a fatal case.
Kato K; Fukuda S; Fujimaki T; Takano Y; Kunii E; Kato K; Watanabe K; Suzuki S; Yamada K; Yokoi K; Mori T
Intern Med; 2009; 48(11):911-3. PubMed ID: 19483360
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
5. Comparative angioscopic evaluation of neointimal coverage and thrombus between TAXUS-Express and TAXUS-Liberté stents: is the stent platform type associated with the vascular response?
Yamamoto M; Takano M; Murakami D; Okamatsu K; Seino Y; Mizuno K
Int J Cardiol; 2010 Dec; 145(3):587-9. PubMed ID: 20580101
[No Abstract] [Full Text] [Related]
6. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R;
N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency.
Syed AI; Ben-Dor I; Collins SD; Gonzalez MA; Gaglia MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Lindsay J; Waksman R
J Interv Cardiol; 2010 Feb; 23(1):33-9. PubMed ID: 20465718
[TBL] [Abstract][Full Text] [Related]
9. Comparison of long-term clinical outcome after successful implantation of Firebird sirolimus- and Taxus paclitaxel-eluting stents in Chinese population: analysis of a large single center registry.
Dou KF; Xu B; Yang YJ; Chen JL; Qiao SB; Wang Y; Li JJ; Qin XW; Yao M; Liu HB; Wu YJ; Chen J; Yuan JQ; You SJ; Li W; Gao RL
Chin Med J (Engl); 2010 Apr; 123(7):810-5. PubMed ID: 20497669
[TBL] [Abstract][Full Text] [Related]
10. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301
[TBL] [Abstract][Full Text] [Related]
11. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
[TBL] [Abstract][Full Text] [Related]
12. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.
Moses JW; Mehran R; Nikolsky E; Lasala JM; Corey W; Albin G; Hirsch C; Leon MB; Russell ME; Ellis SG; Stone GW
J Am Coll Cardiol; 2005 Apr; 45(8):1165-71. PubMed ID: 15837244
[TBL] [Abstract][Full Text] [Related]
13. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
Büllesfeld L; Gerckens U; Müller R; Grube E
Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW;
J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety and efficacy of sirolimus- vs. paclitaxel-eluting stent implantation for acute ST-elevation myocardial infarction: 3-year follow-up of the PROSIT trial.
Kim HS; Lee JH; Lee SW; Kim YH; Park JH; Choi SW; Jeong JO; Seong IW; Rhee KS; Ko JK; Jo SH; Choi YJ
Int J Cardiol; 2011 Mar; 147(2):253-7. PubMed ID: 19783056
[TBL] [Abstract][Full Text] [Related]
16. Three-year outcomes following sirolimus- versus paclitaxel-eluting stent implantation in an unselected population with coronary artery disease (from the REWARDS Registry).
Hanna NN; Gaglia MA; Torguson R; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Maluenda G; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
Am J Cardiol; 2010 Aug; 106(4):504-10. PubMed ID: 20691308
[TBL] [Abstract][Full Text] [Related]
17. Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial.
Park DW; Kim YH; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Seong IW; Lee JH; Tahk SJ; Jeong MH; Jang Y; Cheong SS; Yang JY; Lim DS; Seung KB; Chae JK; Hur SH; Lee SG; Yoon J; Lee NH; Choi YJ; Kim HS; Kim KS; Kim HS; Hong TJ; Park HS; Park SJ
J Am Coll Cardiol; 2010 Oct; 56(15):1187-95. PubMed ID: 20883925
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stent: the emerging technique for the prevention of restenosis.
Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies.
Schofer J; Bode C; Silber S
Herz; 2004 Mar; 29(2):195-200. PubMed ID: 15057441
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]